# Bisphosphonate‐enoxacin inhibit osteoclast formation and function by abrogating RANKL‐induced JNK signalling pathways during osteoporosis treatment

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/bisphosphonate-enoxacin-inhibit-osteoclast-formation-and-function-by-abrogating/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Qiang Xu,Ping Zhan,Xiaofeng Li,Fengbo Mo,Huaen Xu,Yuan Liu,Qi Lai,Bin Zhang,Min Dai,Xuqiang Liu |
| Citations | 22 |
| DOI | 10.1111/jcmm.16949 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcmm.16949 |
| OpenAlex ID | https://openalex.org/W3207413163 |
| PMID | 34651433 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Fengbo Mo](https://scholariq.org/researchers/fengbo-mo/)

## Paper primary topic

- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)

## Paper topics

- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.